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Abstract  
Marketing strategy is correlated with the regulations for the corresponding product category. 
Accordingly, there is a big difference in the marketing strategy of food supplements and over-the-
counter medicines. In this paper are presented 2 different marketing strategies of a new small 
pharmaceutical company in two studies. The findings of studies analysis can be used for 
developing marketing strategies in the wider sense and other products, for other small to medium 
sized companies in other countries of interest with similar regulations and help them understand 
how to position and promote themselves and their products. 
 
 
 
 
 
 
 
Introduction 
 
Marketing strategy differs depending on the 
product, pharmaceutical company and market 
situation. The process consists of 3 phases: planning, 
implementation and control [1-3]. The strategy can 
relate to therapeutic groups, product line or individual 
product [4]. In this paper, 2 different marketing 
strategies of the new small pharmaceutical company 
in two studies will be presented. In Study One will be 
explored marketing strategy for food supplements 
(product line). In Study Two will be explored and 
created a marketing strategy for over-the-counter 
(OTC) medicine (product strategy) for a non-EU 
pharmaceutical company (Macedonia) to enter the EU 
market (Slovenia), based on the comprehensive 
research analysis. Today pharmaceutical companies 
must sell smarter and deliver greater value with 
smaller sales teams. 
Methods 
 
In both studies are used qualitative and 
literature research. Additionally, in Study One are 
used questionnaires for wholesalers and pharmacies 
and competitors analysis. In Study Two are used 
situation analysis (Political, Economic, Regulatory, 
Technological, Social/PERTS & SWOT analysis) and 
interviews with company employees.  
 
 
Results 
 
Study One 
Products are positioned as food supplements 
that support the health of patients. Starting points of 
the strategy are: 
 Brand names of food supplements - easy to 
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remember; 
 Visual differentiation through packaging – 
impressiveness; 
 Abstract display of elements/effects on 
packaging; 
 Modern and clear design - associated with 
modern sophisticated technology. 
The concept for the brand name is to mark 
the effect which food supplements have on the human 
body (some names are a blend of ingredients that are 
contained or the organ for which they are intended, 
others mark the effect). 
On the packages is displayed modern graphic 
typography concept, letters contribute to playfulness, 
visual impressiveness and authenticity, 
complemented by body parts that affect the 
supplements. Organs are presented in an interesting 
cubist manner, by emphasising the tissue as a creator 
of every organ and this gives original minimalist 
outlook that sets it apart as unique packaging sample. 
Communication objectives are: creating 
company awareness, promoting a line of food 
supplements, further education of target audience for 
their action and the way of usage.  
Target audiences are professionals - doctors, 
pharmacists, associations and non-governmental 
organisations, and the general public - medias. 
Limited launch phase (preparatory phase) is 
represented by testing the products with special target 
groups (physicians), building company credibility and 
presentation of products among experts. 
Introduction phase of food supplements is 
represented by presenting the company and 
announcement of products – public relations, launch, 
positioning, point of sale and point of purchase 
support, creating awareness (cooperation with portals 
that have headings for health) through mass 
electronic media - TV and print media campaigns for 
the professionals and general public. 
PR activities: 
1. Presentation of the company - company 
brand through an introduction to general public and 
specific audiences, by demonstrating capacity and 
technology through interviews with selected media. 
Objective: presentation to the public and 
target audiences, promoting investment and 
highlighting the contribution of the company to the 
economy and quality of life. 
Target audience: representatives of medias, 
companies (partners, suppliers, customers), experts, 
general public. 
2. Building credibility - strengthening the 
company position by initiating important topics related 
to contemporary trends in company's interest at target 
audiences. 
3. Products presentation - communication-
related to certain products and advice for their positive 
characteristics using "third party". 
Objective: to inform the public about products 
advantages and characteristics, promotion, 
strengthening confidence in products recommended 
by physicians and pharmacists. 
Target audience: the general public. 
According to the presented data, it is obvious 
that registration of food supplements is not demanding 
as the registration process of medicines, so their 
replacement with other food supplements is also 
easier and predicted. Usually, they are hit products 
which have a shorter life cycle, about 4-5 years, which 
is not the case with the medicines. Requirements in 
terms of investments in the manufacturing facilities, 
equipment and staff are also much smaller in terms of 
requests for necessary good pharmaceutical practices 
that are imperative for the pharmaceutical product 
manufacturers. Manufacturers of food supplements 
need only an HACCP certificate. Food supplements 
pricing is free and is not regulated by law. 
 
Study Two 
Marketing plan for the OTC product is 
developed based on the tabulated data from situation 
analysis - PERTS analysis (Table 1) and SWOT 
analysis (Table 2).  
PERTS analysis model is exploring the 
external factors, particularly useful for international 
markets. 
Table 1: PERTS analysis – macro environment 
External factors Opportunities Threats 
Political 
Reimbursement list and health care 
policies are subject to change 
Removal from reimbursement 
list 
Economic 
Economical situation is improving 
Medicine market grows 
Economic crisis 
Change of exchange rate 
Regulatory Obtaining marketing authorization Regulatory changes 
Technological 
Growth by expanding production with 
semisolid and liquid pharmaceutical 
dosage forms, medical devices and 
cosmetics 
Competition 
New innovative competitors 
technology 
Social 
Direct-to-Consumer pharmaceutical 
advertising 
Good relationships with pharmacists 
and physicians 
Limited economic opportunities 
Dependence on personal   
relationships with pharmacists 
and physicians 
Consumer brand affection 
 
SWOT analysis is an analysis of both, internal 
and external company factors (Table 2). 
Based on two presented analyses, we found 
weak and critical points of the marketing plan and 
process optimisation of the medicine launch (ML) is 
proposed. Optimisation process of ML is important to 
eventually reduce or exclude certain risks that can 
cause failure or poor results. They would have a 
lasting negative effect on the positioning and the 
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image of the company and products in markets where 
growth in sales is expected. 
Table 2: SWOT analysis – micro & macro environment          
   
STRENGTHS 
 
Experienced staff 
Trained sales representatives 
Reputation for quality 
 
WEAKNESSES 
 
Competition is well established and 
employees are well educated 
Limited resources 
Not so innovative products 
 
 
OPPORTUNITIES 
 
Expansion of product portfolio 
Medicine market grows 
Reimbursement list and health care policies 
are subject to change 
Economical situation is improving 
 
 
THREATS 
 
Reduction of prices of competitors 
products 
Decreased interest among distributors due 
to competitive products 
Decreased interest among key 
practitioners 
Removal from reimbursement list 
 
Critical points 
There are more activities and key points 
which are important for the smooth development of 
ML, which may cause difficulties or halt the process if 
not monitored carefully. Involved are the finance 
department, education, legal resources, registration & 
pharmacovigilance, quality control, production, 
research & development, procurement & marketing. 
Some of the activities are well organised, but some 
need to be organised better: 
 
1. Marketing/Management 
Communication is imperative, is very 
important between pharmaceutical company from 
Macedonia and the Slovenian partner responsible for 
the marketing of OTC medicine, as well as managing 
the employees in each of the companies. Employees 
should know to whom to address for certain issues. 
Also, the perception of Slovenian market is important, 
because although there are similarities, there are 
social and cultural differences between Macedonia 
and Slovenia that influence decision-making [5].
 
- Project leader. Important is to appoint the 
project leader who will allocate tasks, monitor the 
activities and implementation of timelines and budget 
frames. This will facilitate to get answers quickly and 
to know always in which phase is ML. 
- Goals. Goals motivate employees to achieve 
them. Goals should be realistic and achievable, in 
order not to cause opposite effect among employees, 
but also should not be too low. They should be 
measurable and specific for certain time period. 
- Communication. It is defined in the plan for 
ML and consists of meeting for ML, limited launch 
phase (LLP), local promotion of medicine, full launch 
phase (FLP) and choice of marketing materials. 
- Sales representatives. OTC medicine is 
scheduled to be sold through sales representatives, 
as well as direct marketing and advertising for the 
general public. Success is depending on whether 
sales representatives are motivated enough. 
- Traceability and communication. It is very 
important for the team to be willing to achieve good 
results. It is necessary to monitor and communicate 
the success or failure, to know at what stage ML is 
and whether earlier stages were successful. 
- Price. Price formation is complex and 
depends on regulation, international markets and 
expectations of the company. Pricing of OTC 
medicines in Macedonia is free, but for example in 
Slovenia [6] and in other countries price is regulated 
by law. 
- LLP centres. Sales representatives should 
select key physicians and centres that will be included 
in the limited launch phase. The country manager 
should decide which of the selected centres are 
crucial and will support OTC medicine. 
- Marketing materials. Once marketing sectors 
agreed on the selection of promotional materials, the 
materials will be translated into Slovenian. Slovenian 
partner has full responsibility for this activity. 
- Organising events. Marketing team 
participates in events organisation by selecting hotels, 
transport, advertising materials and other activities or 
hires PR and travel agencies. 
 
2. Education 
Training level depends on the importance of 
ML. Education will be carried out internally at the 
pharmaceutical company and externally in the 
business partner premises.  
Internal education is the education of sales 
representatives and includes presentations for OTC 
medicine and therapy, and marketing training, as well. 
For all companies, it is important to have experienced 
sales representatives who are continually educated. 
Training should be interesting and useful for the 
participants. 
External education is the education of the 
local partner sales representatives. The external 
educational program will be provided for Slovenian 
physicians and pharmacists, as well. This way, the 
awareness for OTC medicine will be created. 
Participants will acquire information about the way 
and duration of use, packaging, and will have the 
opportunity to test the medicine. 
 
3. Legislation/Regulation 
Laws: legal sector should check earlier legal 
requirements for contracts with distributors, their 
validity and possibility of automatic extending. The 
legal sector could explore the possibility for certain 
exclusivity because the law on anti-monopoly 
behaviour for medicines does not allow exclusivity. 
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Regulation: EU GMP certificate is a 
prerequisite for obtaining medicines marketing 
authorization in EU. Without this certificate, it is not 
possible medicines to be released in EU, also in some 
non-EU countries which have implemented EU 
legislation [7-9]. The process of obtaining EU-GMP 
certificate is complex, laborious and expensive, 
requires great employee’s efforts and lasts minimum 
one year. 
 
Propositions for optimising ML 
- Communication and employee 
management. Managing staff and communication with 
the responsible employee is very important for 
companies; especially in ML. Communication can be 
improved by determining contact responsible person 
for each part. The person manages the flow of 
communications and forwards them to the appropriate 
person. This way the performance and speed are 
improved. PR agency can be engaged, committed to 
publishing texts for OTC medicine, ML and the 
timetable for the launch. Changing this way, 
communication is better and employee involvement is 
greater. 
- Creating campaign. It is very important to 
create a campaign for a certain problem that can be 
cured through the use of OTC medicine. The use of 
medicine can be maximised, where it has not been 
used before or it has been used to a lesser extent (an 
indication for which the medicine has not been 
developed originally, but for which the medicine offers 
an appropriate solution) [10]. Awareness can be 
created through meetings or interviews with 
physicians, pharmacists, consumers, sales 
representatives, and through direct marketing and 
advertising to the general public. This will create 
customers satisfaction, offering a solution to their 
needs. 
- Internal delays. Internal delays may be 
caused by differences in priorities of both partners and 
include late decision making, timelines are not always 
respected, the last moment meeting cancellations. 
Problems can be overcome if more independence is 
given to the Slovenian business partner in decision 
making or by involving more company employees in 
the activities. 
- Marketing materials. Different type of 
promotional materials can be used in marketing. In 
this case, it is important ML, therefore appropriate 
materials for ML have to be chosen. It is important 
because not all marketing materials have the same 
importance in different approaches of marketing 
strategies. Marketing materials should be ordered and 
delivered on time. 
- Production/Procurement, Distribution. 
Although forecasts and orders can be given in time, 
there may be delays in transportation /delivery of the 
product (e.g., delay in clearance), problems can arise 
in production, delay in delivery of any material which 
enters the manufacturing process of medicine, leading 
to time prolongation in planned deliveries. One 
solution could be storing larger stock of necessary raw 
materials, which requires more storage space and 
brings higher costs. A better solution would be closely 
monitoring of all activities and full involvement by the 
responsible persons from the company. This would 
make possible more objective and effective product 
distribution (certain product quantities for specific 
region) based on the regional sales data.  
Because of the size of investment and 
expectations, the approach in marketing strategy 
development is much more serious, more complex 
and broader for OTC medicines. The presented data 
show that LLP and FLP reference centers are 
selected very carefully, critical points are set and 
monitored, proposals for optimization of ML are given, 
in order to avoid any marketing strategy delay or 
failure, which would have long lasting negative effect 
on the positioning and image of the pharmaceutical 
company and products in markets where sales growth 
is expected. As the product is OTC medicine, the 
approach must be supported with much more 
scientific data and therefore patients and healthcare 
professionals take them very seriously. 
In conclusion, marketing strategy is correlated 
with the regulations for the corresponding product 
category. Registration of food supplements is easier 
and much quicker than registration of medicines. As a 
result, there is a big difference in the marketing 
strategy of food supplements and OTC medicines. 
Studied findings can be used for developing marketing 
strategies in the wider sense and other products, for 
other small to medium sized companies in other 
countries of interest with similar regulations. 
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